Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis. (2015). Archivio Italiano Di Urologia E Andrologia, 87(2), 121-129. https://doi.org/10.4081/aiua.2015.2.121